PCMag editors select and review products independently. If you buy through affiliate links, we may earn commissions, which help support our testing.

Google Settles Probe Into Illegal Online Drug Ads for $500M

 & Chloe Albanesius Executive Editor, News

Our team tests, rates, and reviews more than 1,500 products each year to help you make better buying decisions and get more from technology.

Our Expert
LOOK INSIDE PC LABS HOW WE TEST
65 EXPERTS
43 YEARS
41,500+ REVIEWS

Google will pay $500 million in fines over AdWords sales that allowed U.S. residents to access ads for online Canadian pharmacies, the Department of Justice announced Wednesday.

Those ads led to sites selling prescription drugs from Canadian pharmacies, which were then illegally imported into the United States. The $500 million forfeiture, which the DOJ said is the largest ever in the U.S., is the gross revenue that Google received from Canadian pharmacy-related AdWords sales plus the gross revenue earned by Canadian pharmacies that sold drugs to U.S. consumers, the agency said.

"This settlement ensures that Google will reform its improper advertising practices with regard to these pharmacies while paying one of the largest financial forfeiture penalties in history," Deputy Attorney General James M. Cole said in a statement.

In addition to the $500 million, the deal includes several compliance and reporting measures with which Google must comply.

"We banned the advertising of prescription drugs in the U.S. by Canadian pharmacies some time ago. However, it's obvious with hindsight that we shouldn't have allowed these ads on Google in the first place," Google said in a Wednesday statement.

Google declined to provide further comment on the matter "given the extensive coverage this settlement." It's not the first time the company has spoken out on the issue, however. In September 2010, it filed suit against advertisers it believed had broken its rules and advertised illegally via AdWords. At the time, Google said the problem was an "ongoing, escalating cat-and-mouse game" that has grown in sophistication over the years.

The DOJ investigation was spearheaded by the U.S. Attorney's Office in Rhode Island and the FDA/OCI Rhode Island Task Force. Officials first became aware of the issue thanks to a separate financial fraud investigation unrelated to Google. The agency apprehended a man who used AdWords to sell drugs online, and he provided them with details on how it was done. The DOJ even set up a few undercover Web sites for the purpose of selling drugs via AdWords.

Justice officials said Google "was on notice" as early as 2003 about the Canadian pharmacy sales. While the search giant took steps to ban other countries from selling drugs in the U.S., DOJ said Google "continued to allow Canadian pharmacy advertisers to target consumers in the United States," providing customer support to some of these companies from 2003 to 2009.

In 2009, however, Google was made aware of the Rhode Island investigation and took steps to stop its support of these companies. Google started requiring online pharmacy advertisers to be certified by the National Association of Boards of Pharmacy's Verified Internet Pharmacy Practices Sites program and hired an outside company to detect pharmacy advertisers exploiting flaws in the Google's screening systems, the DOJ said.

Importing prescription drugs into the U.S. from Canada and elsewhere is illegal because the Food and Drug Administration (FDA) cannot ensure their safety.

About Our Expert

Chloe Albanesius

Chloe Albanesius

Executive Editor, News

My Experience

I started out covering tech policy in DC for The National Journal, where my beat included state-level tech news and all the congressional hearings and FCC meetings I could handle. I later covered Wall Street trading tech before switching gears to consumer tech. I now lead PCMag's news coverage.

My Areas of Expertise

Getting my start in DC means I still have a soft spot for tech policy; Congressional hearings can sometimes be as entertaining as a Bravo reality show, for better or worse. But PCMag is all about the technology we use every day, as well as keeping an eye out for the trends that will shape the industry in the years ahead (or flop on arrival). I've covered the rise of social media, the iOS vs. Android wars, the cord-cutting revolution that's now left us with hefty streaming bills, and the effort to stuff artificial intelligence into every product you could imagine. This job has taken me to CES in Vegas (one too many times), IFA in Berlin, and MWC in Barcelona. I also drove a Tesla 1,000 miles out west as part of our Best Mobile Networks project. Of late, my focus is on our hard-working team of reporters at PCMag, guiding and editing their robust coverage.

Read full bio